Human Vaccines and Immunotherapeutics
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.2 | Q2 | 64.5% | 1.094 | Q1 | 86.1% |
| 2024 | 3.5 | Q2 | 63.8% | 0.897 | Q2 | 81.3% |
| 2023 | 4.1 | Q2 | 57.1% | 0.927 | Q1 | 83.6% |
| 2022 | 4.8 | Q1 | 57.3% | 1.041 | Q1 | 87.1% |
| 2021 | 4.5 | Q3 | 51.0% | 1.073 | Q1 | 88.0% |
| 2020 | — | — | 1.043 | Q1 | 86.2% | |
| 2019 | — | — | 1.088 | Q1 | 87.4% | |
| 2018 | — | — | 0.989 | Q1 | 83.9% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2164-554X
ISSN
2164-5515
country
UScoverage
2012-2026